Sanofi ADR (NASDAQ:SNY) shares, rose in value, with the stock price down by -0.76% to the previous day’s close as strong demand from buyers drove the stock to $51.99.
Actively observing the price movement in the last trading, the stock closed the session at $52.39. The PE ratio was 21.71 over 12-month period. Referring to stock’s 52-week performance, its high was $60.12, and the low was $45.80. On the whole, SNY has fluctuated by -1.46% over the past month.
With the market capitalization of Sanofi ADR currently standing at about $126.67 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 2.21, with its dividend yield at 4.26%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SNY’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.67, with the price of SNY currently trading nearly -0.62% and -1.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.34, while the 7-day volatility ratio is showing 0.82% which for the 30-day chart, stands at 2.00%. Furthermore, Sanofi ADR (SNY)’s beta value is 0.51, and its average true range (ATR) is 1.11.
A comparison of Sanofi ADR (SNY) with its peers suggests the former has fared considerably weaker in the market. SNY showed an intraday change of -0.76% in last session, and over the past year, it grew by 6.10%%.
Data on historical trading for Sanofi ADR (NASDAQ:SNY) indicates that the trading volumes over the past 3 months, they’ve averaged 2.90 million. According to company’s latest data on outstanding shares, there are 2.61 billion shares outstanding.
Nearly 0.02% of Sanofi ADR’s shares belong to company insiders and institutional investors own 10.73% of the company’s shares. The stock has risen by 7.80% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SNY stock heading into the next quarter.
